Medicine for treating shell allergic diseases and processing technology thereof

Abstract

The invention discloses a medicine for treating shell allergic diseases and a processing technology thereof. The medicine is prepared from the following components in parts by weight: 30-55 parts of shells, 11-22 parts of ecklonia kurome okam, 5-12 parts of laver, 4-13 parts of seaweed, 11-27 parts of herba dendrobii, 5-24 parts of ramulus cinnamomi, 4-26 parts of periostracum cicadae, 6-20 parts of radix saposhnikoviae, 4-17 parts of cortex eucommiae, 1-10 parts of fructus corni, 2-20 parts of longan, 1-14 parts of semen phaseoli, 3-15 parts of semen torreya and 2-14 parts of black dates. The preparation method comprises the following steps: soaking raw materials in water, drying in the shade, crushing and extracting, adding special white spirit for baking, and finally performing secondary nano-crushing to obtain finished medicinal powder. The treatment thought of repairing an immune system is adopted, the immune system is repaired through inorganic matters corresponding to organic matters causing allergic diseases, and the corresponding shells are used for treating allergic diseases aiming at different allergens causing allergic symptoms.

Description

technical field [0001] The invention relates to the technical fields of medicine, health food and food additives, in particular to a medicine for treating shell allergic diseases and a processing technology thereof. Background technique [0002] Allergic diseases are also known as "allergic diseases". Common allergic diseases include allergic dermatitis, allergic rhinitis, allergic asthma, anaphylactic shock, etc., which are common clinical diseases and frequently-occurring diseases. With the development of society and economy, the change of diet structure and living environment, the incidence of allergic diseases is increasing year by year worldwide. According to the statistics released by the World Allergy Organization (WAO), in the past 30 years, the incidence of allergic diseases The prevalence rate has increased by at least 3 times, and the global total prevalence rate has reached 22%. It is estimated that 50% of the population in industrialized countries will suffer fr...

AI Technical Summary

Problems solved by technology

[0006] Due to the ubiquity and commonness of allergens, allergic patients may inadvertently contact, inhale or ingest allergens, and then produce allergic reactions, and even shock and acute death

[0007] Second, allergic patients will get sick when they encounter allergens, and they are prone to repeated attacks and difficult to cure

[0012] (3) Patients who lack compliance should not use it